The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
TGF-β Family Signaling in Tumor Suppression and Cancer Progression
Open accessAbstract
Transforming growth factor-β (TGF-β) induces a pleiotropic pathway that is modulated by the cellular context and its integration with other signaling pathways. In cancer, the pleiotropic reaction to TGF-β leads to a diverse and varied set of gene responses that range from cytostatic and apoptotic tumor-suppressive ones in early stage tumors, to proliferative, invasive, angiogenic, and oncogenic ones in advanced cancer. Here, we review the knowledge accumulated about the molecular mechanisms involved in the dual response to TGF-β in cancer, and how tumor cells evolve to evade the tumor-suppressive responses of this signaling pathway and then hijack the signal, converting it into an oncogenic factor. Only through the detailed study of this complexity can the suitability of the TGF-β pathway as a therapeutic target against cancer be evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast
Walker, R. A., & Dearing, S. J. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80116-9 · Cited by 151
Snail1 suppresses TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes
Franco, D. L., Mainez, J., Vega, S., Sancho, P., Murillo, M. M., de Frutos, C. A., del Castillo, G., López-Blau, C., Fabregat, I., & Nieto, M. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.068692 · Cited by 151
Chen, T., Carter, D., Garrigue‐Antar, L., & Reiss, M. (1998) · PubMed · Cited by 150
Zhang, Q., Yang, X. J., Pins, M., Javonovic, B., Kuzel, T. M., Kim, S., Parijs, L. V., Greenberg, N. M., Liu, V., Guo, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3169 · Cited by 149
Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP–HHT syndrome
Gallione, C. J., Aylsworth, A. S., Beis, J., Berk, T., Bernhardt, B. A., Clark, R. D., Clericuzio, C. L., Danesino, C., Drautz, J. M., Fahl, J., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33206 · Cited by 147
PARP-1 Attenuates Smad-Mediated Transcription
Lönn, P., van der Heide, L. P., Dahl, M., Hellman, U., Heldin, C., & Moustakas, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.029 · Cited by 147
Modulation of the Immune Response by Transforming Growth Factor Beta
Fontana, A., Constam, D. B., Frei, K., Malipiero, U., & Pfister, H. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236328 · Cited by 146
Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors
Goto, K., Kamiya, Y., Imamura, T., Miyazono, K., & Miyazawa, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702100200 · Cited by 145
Capparelli, C., Whitaker‐Menezes, D., Guido, C., Balliet, R. M., Pestell, T. G., Howell, A., Sneddon, S., Pestell, R. G., Martinez‐Outschoorn, U., Lisanti, M. P., et al. (2012) · Cell Cycle · doi:10.4161/cc.20717 · Cited by 143
A., C. A. C., Younes, P. S., Laucirica, R., & Rosen, J. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1887 · Cited by 139
TGFβ and matrix-regulated epithelial to mesenchymal transition
Moustakas, A., & Heldin, P. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.02.004 · Cited by 136
Upregulation of two BH3-only proteins, Bmf and Bim, during TGFβ-induced apoptosis
Ramjaun, A. R., Tomlinson, S., Eddaoudi, A., & Downward, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209852 · Cited by 131
Distinct Domain Utilization by Smad3 and Smad4 for Nucleoporin Interaction and Nuclear Import
Xu, L., Alarcón, C. R., Çöl, S., & Massagué, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307601200 · Cited by 127
Luo, K., & Lodish, H. F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1970 · Cited by 126
Genetics, genomics, and evolutionary biology of NKG 2D ligands
Carapito, R., & Bahram, S. (2015) · Immunological Reviews · doi:10.1111/imr.12328 · Cited by 125
Wang, D., Kanuma, T., Mizunuma, H., Takama, F., Ibuki, Y., Wake, N., Mogi, A., Shitara, Y., & Takenoshita, S. (2000) · PubMed · Cited by 121
Physiology of the Renal Interstitium
Zeisberg, M., & Kalluri, R. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00640114 · Cited by 118
Swarbrick, A., Roy, E., Allen, T., & Bishop, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801505105 · Cited by 111
Ohgushi, M., Kuroki, S., Fukamachi, H., O’Reilly, L. A., Kuida, K., Strasser, A., & Yonehara, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10017-10028.2005 · Cited by 109
Dual Role of SnoN in Mammalian Tumorigenesis
Zhu, Q., Krakowski, A., Dunham, E. E., Wang, L., Bandyopadhyay, A. M., Berdeaux, R., Martin, G. S., Sun, L., & Luo, K. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01394-06 · Cited by 108
Wolfraim, L. A., Walz, T. M., James, Z., Fernandez, T., & Letterio, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3093 · Cited by 105
Kleeff, J. H., Maruyama, H., Frieß, H., Büchler, M. W., Falb, D., & Korc, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0171 · Cited by 105
The activin axis in liver biology and disease
Rodgarkia‐Dara, C., Vejda, S., Erlach, N., Losert, A., Bursch, W., Berger, W., Schulte‐Hermann, R., & Grusch, M. (2006) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.07.002 · Cited by 103
Buck, M. B., Fritz, P., Dippon, J., Zugmaier, G., & Knabbe, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0320-03 · Cited by 100
Tang, B., Yoo, N., Vu, M. A., Mamura, M., Nam, J., Ooshima, A., Du, Z., Desprez, P. Y., Anver, M. R., Michalowska, A. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0982 · Cited by 99
Wang, J., Yang, L., Yang, J., Kuropatwinski, K. K., Wang, W., Liu, X.-Q., Hauser, J., & Brattain, M. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5348 · Cited by 98
Ding, W., Mouzaki, M., You, H., Laird, J. C., Mato, J. M., Lu, S. C.-L., & Rountree, B. C. (2008) · Hepatology · doi:10.1002/hep.22743 · Cited by 97
Ito, N., Kawata, S., Tamura, S., Shirai, Y., Kiso, S., Tsushima, H., & Matsuzawa, Y. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)90156-6 · Cited by 96
Ramesh, S., Qi, X., Wildey, G. M., Robinson, J., Molkentin, J. D., Letterio, J. J., & Howe, P. H. (2008) · EMBO Reports · doi:10.1038/embor.2008.158 · Cited by 91
Monitoring tissue repair and fibrosis from a distance.
Kt, W. (1997) · PubMed · Cited by 91
Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma.
Barrett, M. T., Schutte, M. E. M., Kern, S. E., & Reid, B. J. (1996) · PubMed · Cited by 89
Franklin, C. C., Rosenfeld, M. E., White, C. C., Kavanagh, T. J., & Fausto, N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0867fje · Cited by 88
Active CREB1 Promotes a Malignant TGFβ2 Autocrine Loop in Glioblastoma
Rodón, L., Gonzàlez-Juncà, A., Inda, M. D. M., Sala-Hojman, A., Martínez-Sáez, E. A., & Seoane, J. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0275 · Cited by 85
Self-citationThe role of transforming growth factor Β in glioma progression
Jennings, M. T., & Pietenpol, J. A. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005863419880 · Cited by 85
Ma, D., & Niederkorn, J. Y. (1995) · PubMed Central · Cited by 84
Smad7 induces hepatic metastasis in colorectal cancer
Halder, S., Rachakonda, G., Deane, N. G., & Datta, P. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604562 · Cited by 83
CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stroma
Shukla, A., Edwards, R., Yang, Y.-A., Hahn, A., Folkers, K., Ding, J., Padmakumar, V. C., Cataisson, C., Suh, K. S., & Yuspa, S. H. (2013) · Oncogene · doi:10.1038/onc.2013.18 · Cited by 81
Microsatellite instability and mutated type II transforming growth factor-β receptor gene in gliomas
Izumoto, S., Arita, N., Ohnishi, T., Hiraga, S., Taki, T., Tomita, N., Ohue, M., & Hayakawa, T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04583-1 · Cited by 81
TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia
Letterio, J. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208922 · Cited by 78
Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression
Yang, J., Song, K. W., Krebs, T. L., Jackson, M. W., & Danielpour, D. (2008) · Oncogene · doi:10.1038/onc.2008.165 · Cited by 76
Arteaga, C. L., Koli, K., Dugger, T. C., & Clarke, R. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.46 · Cited by 75
Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting Gene
Tarragona, M., Pavlović, M., Estape, A. A., Urosevic, J., Morales, M. L. G., Guiu, M., Planet, E., González‐Suárez, E., & Gomis, R. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355834 · Cited by 75
Self-citationChoi, S.-H., Nam, J.-K., Kim, B., Jang, J.-H., Jin, Y.-B., Lee, H., Park, S. W., Ji, Y. H., Cho, J., & Lee, Y.-J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0952 · Cited by 74
Molecular Characterization of Rat Transforming Growth Factor-β Type II Receptor
Tsuchida, K., Lewis, K. A., Mathews, L. S., & Vale, W. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1286 · Cited by 73
Nuclear Targeting of Transforming Growth Factor-β-activated Smad Complexes
Chen, H. B., Rud, J., Lin, K. F., & Xu, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500362200 · Cited by 68
Lei, J.-Y., Zou, T., Shi, Y. Q., Zhou, X., Smolinski, K. N., Yin, J., Souza, R. F., Appel, R., Wang, S., Cymes, K., et al. (1996) · PubMed · Cited by 66
Naka, K., Jomen, Y., Ishihara, K., Kim, J., Ishimoto, T., Bae, E., Mohney, R. P., Stirdivant, S. M., Oshima, H., Oshima, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9039 · Cited by 65
Li, X., Sterling, J. A. R., Fan, K.-H., Vessella, R. L., Shyr, Y., Hayward, S. W., Matrisian, L. M., & Bhowmick, N. A. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0506 · Cited by 65
Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response
Fernandez, M. L. O., Recio-Poveda, L., Aristorena, M., Lastres, P., Blanco, F. J., Sanz-Rodrı́guez, F., Gallardo‐Vara, E., Casas-Engel, M. D. L., Corbí, A. L., Arthur, H. M., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005935 · Cited by 64
Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines
Cerutti, J. M., Ebina, K. N., Matsuo, S. E., Martins, L., Maciel, R. M. B., & Kimura, E. T. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345213 · Cited by 61
Overexpression of the TGF-β antagonist Smad7 in endometrial cancer
Dowdy, S. C., Mariani, A., Reinholz, M. M., Keeney, G. L., Spelsberg, T. C., Podratz, K. C., & Janknecht, R. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.006 · Cited by 59
TGFβ1-Induced Activation of ATM and p53 Mediates Apoptosis in a Smad7-Dependent Manner
Zhang, S., Ekman, M., Thakur, N., Bu, S., Davoodpour, P., Grimsby, S., Tagami, S., Heldin, C., & Landström, M. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3523 · Cited by 58
Zhang, F., Lee, J., Lu, S., Pettaway, C. A., & Dong, Z. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2571 · Cited by 57
Park, J. A., Wang, E., Kurt, R. A., Schluter, S. F., Hersh, E. M., & Akporiaye, E. T. (1997) · PubMed · Cited by 56
Shima, K., Morikawa, T., Yamauchi, M., Kuchiba, A., Imamura, Y., Liao, X., Meyerhardt, J. A., Fuchs, C. S., & Ogino, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025062 · Cited by 50
Hawinkels, L. J. A. C., Verspaget, H. W., van der Reijden, J. J., Zon, J. M. V. D., Verheijen, J. H., Hommes, D. W., Lamers, C. B. H. W., & Sier, C. F. M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01100.x · Cited by 49
Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G. J., Loda, M. F., & Fuchs, C. S. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.10.005 · Cited by 49
Alieva, D. G., Walker, T. M., & Elgert, K. D. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.6.919 · Cited by 46
HER2 Silences Tumor Suppression in Breast Cancer Cells by Switching Expression of C/EBPβ Isoforms
Estape, A. A., Tarragona, M., Morales, M. L. G., Guiu, M., Nadal, C., Massagué, J., & Gomis, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0869 · Cited by 46
Self-citationTransforming growth factor-β1 inhibits activation of macrophage cell line RAW 264.7 for cell killing
Haak‐Frendscho, M., Wynn, T. A., Czuprynski, C. J., & Paulnock, D. M. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05461.x · Cited by 34
Resistance to TGF‐β‐induced apoptosis in regenerating hepatocytes
Herrera, B. M., Alvarez, A. M., Beltrán, J., Valdés, F., Fabregat, I., & Fernández, M. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20078 · Cited by 28
Novitskiy, S. V., Forrester, E., Pickup, M. W., Gorska, A. E., Chytil, A., Aakre, M. E., Polosukhina, D., Owens, P., Yusupova, D. R., Zhao, Z., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0425-7 · Cited by 22
Production of Gastrointestinal Tumors in Mice by Modulating Latent TGF-β1 Activation
Shibahara, K., Ota, M., Horiguchi, M., Yoshinaga, K., Melamed, J., & Rifkin, D. B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3141 · Cited by 16
Kontani, K., Kajino, K., Huangi, C.-L., Fujino, S., Taguchi, O., Yamauchi, A., Yokomise, H., & Ogasawara, K. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0044-3 · Cited by 13
Cited by
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01569-x · Cited by 1,065
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Specificity, versatility, and control of TGF-β family signaling
Derynck, R., & Budi, E. H. (2019) · Science Signaling · doi:10.1126/scisignal.aav5183 · Cited by 785
Dynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Metadata
- Authors
- Seoane, J., & Gomis, R. R.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-02-28
- Volume
- 9
- Issue
- 12
- Pages
- a022277
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2592339836
- Cited by
- 510
- References
- 264
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.